Agomelatine as a novel treatment option in panic disorder, results from an 8-week open-label trial

K.M.L. Huijbregts, N.M. Batelaan, J. Schonenberg, G. Veen, A.J.L.M. van Balkom

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)336-338
JournalJournal of Clinical Psychopharmacology
Volume35
Issue number3
DOIs
Publication statusPublished - 2015

Cite this

@article{1e0cbeefd39b4892b219c77d67f1378d,
title = "Agomelatine as a novel treatment option in panic disorder, results from an 8-week open-label trial",
author = "K.M.L. Huijbregts and N.M. Batelaan and J. Schonenberg and G. Veen and {van Balkom}, A.J.L.M.",
year = "2015",
doi = "10.1097/JCP.0000000000000313",
language = "Undefined/Unknown",
volume = "35",
pages = "336--338",
journal = "Journal of Clinical Psychopharmacology",
issn = "0271-0749",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

Agomelatine as a novel treatment option in panic disorder, results from an 8-week open-label trial. / Huijbregts, K.M.L.; Batelaan, N.M.; Schonenberg, J.; Veen, G.; van Balkom, A.J.L.M.

In: Journal of Clinical Psychopharmacology, Vol. 35, No. 3, 2015, p. 336-338.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Agomelatine as a novel treatment option in panic disorder, results from an 8-week open-label trial

AU - Huijbregts, K.M.L.

AU - Batelaan, N.M.

AU - Schonenberg, J.

AU - Veen, G.

AU - van Balkom, A.J.L.M.

PY - 2015

Y1 - 2015

U2 - 10.1097/JCP.0000000000000313

DO - 10.1097/JCP.0000000000000313

M3 - Article

VL - 35

SP - 336

EP - 338

JO - Journal of Clinical Psychopharmacology

JF - Journal of Clinical Psychopharmacology

SN - 0271-0749

IS - 3

ER -